Drug Delivery

Papers
(The H4-Index of Drug Delivery is 41. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Acoustic triggered nanobomb for US imaging guided sonodynamic therapy and activating antitumor immunity252
Development of microparticles for oral administration of Periplaneta americana extract to treat ulcerative colitis199
The development and evaluation of hyaluronic acid coated mitochondrial targeting liposomes for celastrol delivery192
Transdermal delivery of colchicine using dissolvable microneedle arrays for the treatment of acute gout in a rat model170
Recent progress in nanotechnology-based drug carriers for resveratrol delivery104
Hyaluronic acid-based nanoparticles to deliver drugs to the ocular posterior segment92
Exploring the effects of cannabidiol encapsulation in liposomes on their physicochemical properties and biocompatibility88
Electroporation induced changes in extracellular vesicle profile84
Advanced hydrogel material for colorectal cancer treatment81
Functional ligands for improving anticancer drug therapy: current status and applications to drug delivery systems78
Luteolin-loaded exosomes derived from bone marrow mesenchymal stem cells: a promising therapy for liver fibrosis76
Rapid oral transmucosal delivery of zaleplon–lavender oil utilizing self-nanoemulsifying lyophilized tablets technology: development, optimization and pharmacokinetic evaluation72
Co-delivery of amphotericin B and pentamidine loaded niosomal gel for the treatment of Cutaneous leishmaniasis70
Oral liposomal delivery of an activatable budesonide prodrug reduces colitis in experimental mice69
Immunomodulatory nano-preparations for rheumatoid arthritis65
Development of a single-dose Q fever vaccine with an injectable nanoparticle-loaded hydrogel: effect of sustained co-delivery of antigen and adjuvant64
Thermo-sensitive self-assembly of poly(ethylene imine)/(phenylthio) acetic acid ion pair in surfactant solutions62
Electrospun PVP/HPBCD nanofiber topical drug delivery platform for enhanced skin permeability and anti-pollution bioactivity of Artocarpus altilis extrac61
Cannabidiol lymphatic transport after oral administration assessed using a novel thoracic lymph duct cannulated conscious pig model60
Correction58
Quantitative analysis of therapeutic proteins in biological fluids: recent advancement in analytical techniques56
The role of lipid particle-laden interfaces in regulating the co-delivery of two hydrophobic actives from o/w emulsions55
Surface functionalized nanomaterial systems for targeted therapy of endocrine related tumors: a review of recent advancements55
Pitavastatin-loaded bilosomes for oral treatment of hepatocellular carcinoma: a repurposing approach52
Correction52
Formulation of novel niosomal repaglinide chewable tablets using coprocessed excipients: in vitro characterization, optimization and enhanced hypoglycemic activity in rats50
Effect and mechanism of paclitaxel loaded on magnetic Fe 3 O 4 @mSiO 2 -NH 249
Enhancement of the oral bioavailability of isopropoxy benzene guanidine though complexation with hydroxypropyl-β-cyclodextrin49
SREKA-targeted liposomes for highly metastatic breast cancer therapy48
Boosting the anti MERS-CoV activity and oral bioavailability of resveratrol via PEG-stabilized emulsomal nano-carrier: Factorial design, in-vitro and in-vivo assessments47
Recent trends in platelet membrane-cloaked nanoparticles for application of inflammatory diseases46
Exploring the efficacy and constraints of platinum nanoparticles as adjuvant therapy in silicosis management46
Advance in placenta drug delivery: concern for placenta-originated disease therapy44
Platinum-based drugs and hydrogel: a promising anti-tumor combination44
Nanoparticles-based anti-aging treatment of Alzheimer’s disease44
Disordered mesoporous silica particles: an emerging platform to deliver proteins to the lungs43
Targeting interleukin-13 receptor α2 (IL-13Rα2) for glioblastoma therapy with surface functionalized nanocarriers43
Tumor microenvironment-responsive conformational activation of apoA-I mimetic peptides for targeted cancer therapy42
Nanotransethosomes for enhanced transdermal delivery of mangiferin against rheumatoid arthritis: formulation, characterization, invivo pharmacokinetic and pharmacodynamic evaluation42
Multiple delivery strategies of nanocarriers for myocardial ischemia-reperfusion injury: current strategies and future prospective42
The development of DNA delivery system based on ionic liquid and carboxylic acid modified polyethyleneimine41
0.24165010452271